Dupuy, M.; Iltache, S.; Rivière, B.; Prieur, A.; Pageaux, G.P.; Bedoya, J.U.; Faure, S.; Guillaumée, H.; Assenat, E.
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Cancers 2022, 14, 402.
https://doi.org/10.3390/cancers14020402
AMA Style
Dupuy M, Iltache S, Rivière B, Prieur A, Pageaux GP, Bedoya JU, Faure S, Guillaumée H, Assenat E.
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Cancers. 2022; 14(2):402.
https://doi.org/10.3390/cancers14020402
Chicago/Turabian Style
Dupuy, Marie, Sarah Iltache, Benjamin Rivière, Alexandre Prieur, George Philippe Pageaux, José Ursic Bedoya, Stéphanie Faure, Heloïse Guillaumée, and Eric Assenat.
2022. "Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma" Cancers 14, no. 2: 402.
https://doi.org/10.3390/cancers14020402
APA Style
Dupuy, M., Iltache, S., Rivière, B., Prieur, A., Pageaux, G. P., Bedoya, J. U., Faure, S., Guillaumée, H., & Assenat, E.
(2022). Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Cancers, 14(2), 402.
https://doi.org/10.3390/cancers14020402